BRKR - Bruker Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Bruker Corporation

40 Manning Road
Billerica, MA 01821
United States
978-663-3660
http://www.bruker.com

SectorHealthcare
IndustryMedical Laboratories & Research
Full Time Employees6,000

Key Executives

NameTitlePayExercisedAge
Dr. Frank H. Laukien Ph.D.Chairman, Chief Exec. Officer and Pres1.4M31.22k57
Mr. Anthony L. MattacchioneCFO & Sr. VP773.17kN/A54
Dr. Mark R. Munch Ph.D.Exec. VP, Pres of Bruker Nano Surfaces Division and Pres of Bruker Nano Group714.78k967.18k55
Mr. Juergen SregaPres of Bruker Daltonics Division and Pres of Bruker CALID Group523.97kN/A62
Stacey DesrochersTreasurer & Director of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide. The company operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear and explosive detection in emergency response, homeland security, and defense applications; and analytical and process analysis instruments and solutions. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and big science research. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and various other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

Corporate Governance

Bruker Corporation’s ISS Governance QualityScore as of December 1, 2017 is 7. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 4; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.